Aversa Fentanyl holds the potential to become the world’s first abuse-deterrent opioid patch.

Biosimilars sales were $201.5 million, up 7% driven by Benepali, with sales of $125 million, up 16%. LEQEMBI global in-market sales in the quarter were approximately $87 million, including U.S.

Will significantly enhance service to researchers and institutions across China.

New 5mg tablet offers the same established efficacy and safety as the Evrysdi oral solution for individuals living with spinal muscular atrophy.

Sygnature Discovery has appointed Fraser McIntosh as Vice President, In Vivo Pharmacology. Fraser will lead the company’s in vivo drug discovery operations worldwide.

AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, is expanding the scope and ...

Alcami Corporation, a contract development and manufacturing organization (CDMO), has appointed pharmaceutical industry ...

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to CUSP06, a Cadherin-6 targeting ...

Demonstrates its commitment to safeguarding sensitive information and adhering to global standards.

The project is set to become the largest GMP temperature-controlled facility fully dedicated to the life sciences sector in ...

SK pharmteco, a global contract development and manufacturing organization (CDMO), has launched an enhanced analytical testing laboratory specifically dedicated to High Potency Active Pharmaceutical ...

Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery ...